Lipidologist, IntMed/Peds, VP Foundation of National Lipid Assn, Passion = Lipids, telehealth, healthy futures for kids & adults. Tweets r not medical advice
WI
Joined November 2013
- Tweets678
- Following436
- Followers754
- Likes2K
Ann Liebeskind, MD retweeted
If you haven't listened to our latest Lipid Insights episode yet, tonight is a great time to catch up!🎙️
In honor of #FHAwarenessDay, guest host Ann Liebeskind, MD, FNLA, FAAP sits down with Jose Lopez, MS — recipient of the Donald Hunninghake, MD, Familial Hypercholesterolemia Abstract Award — to discuss his award-winning research on early FH detection through point-of-care testing in 2-year-olds.
A meaningful listen to close out #FHAwarenessDay.🫀
Listen on your favorite podcast platform or watch on YouTube 👉 youtu.be/_KvEsDzcgxE
#FamilialHypercholesterolemia #KnowFH #Lipidology #CardiovascularPrevention
Ann Liebeskind, MD retweeted
The 2026 #NLASessions is officially underway, and we couldn’t have asked for a better start to our time in Chicago!
We kicked off the day by wrapping up our three pre-conference courses before diving into a full agenda of learning and connection. The day continued with two Expert Theaters and the Opening Session before ending at the Welcome Reception, where our incredible lipid community got to reconnect.
Tomorrow’s schedule is just as exciting, with @VindicoMedEd’s breakfast symposium, gene editing, Late Breakers, the NLA/EAS Joint Session, and much more on deck.
Rest up and get ready for another action-packed day at #NLASessions!
Ann Liebeskind, MD retweeted
And it starts today!! Just arrived in Chicago and ready to see all the Lipid Nerds!! #NLASessions @nationallipid @lipiddoc @EugeniaGianos @Dr_Zahid_Ahmad @carolkirkpat3 @MarlysLPA @CBallantyneMD
Pause, screenshot, and save the dates! Three epic evenings are waiting for you at #NLASessions in Chicago.💥
🥂 Night 1: Opening Night Kickoff Reception
Reconnect with familiar faces, meet our incredible supporters, and make a few new friends.
🧠 Night 2: NLA Trivia Hour
Casual vibes, light bites, drinks, and a few rounds of trivia. We call that a perfect night.
🏆 Night 3: Honors & Awards Ceremony
Celebrate your peers for their leadership, service, and outstanding achievements. The best way to close out an extraordinary meeting.
Not registered yet? There's still time → lipid.org/sessions
#Lipidology #CardiometabolicHealth #PreventiveCardiology
Ann Liebeskind, MD retweeted
The NLA and @foundationofnla are on the floor at #ACC26! @ACCintouch
We're here for all the big discussions, especially around the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline and the latest in #PreventiveCardiology.
Find us at booth 2353 for patient and clinician resources. Come say hi!👋
#Lipidology #Dyslipidemia #Cardiology
Ann Liebeskind, MD retweeted
Build a strong foundation in clinical lipidology — without leaving home!🧑💻
Join the NLA’s Foundations in Lipidology course Feb 16–17, 2026, offered virtually via Zoom. This expert-led program covers the essentials of lipid management and diagnosis.
Don’t miss the only virtual offering in 2026! Sign up👉lipid.org/foundations
Ann Liebeskind, MD retweeted
LDL-C: The earlier you start and the longer you maintain lowering, the less lowering you need.
@ProfKausikRay #NLASessions @nationallipid @CBallantyneMD @LipidCNS
Ann Liebeskind, MD retweeted
Congrats @nationallipid #NLASessions on a fantastic opening session including incredible overview of CETPi by Dr. Ann Marie Navar, highlighting ⬇️Lp(a), plus past and current trials
@ProfKausikRay @MarlysLPA @CBallantyneMD @PamTaubMD @mdavidsonmd @JohnKastelein @hsbhatia
Ann Liebeskind, MD retweeted
Today's #LipidXcellence comes to us from the @foundationofnla with their #TweetorialTuesday breaking down what your patients need to know about lipid testing and what resources are available to them! Share with your patients! #CholesterolMonth #LipidXcellence #KnowledgeIsPower
We are happy to support @nationallipid for National #CholesterolEducationMonth with this week's Tuesday Tweetorial featuring key info you should know about your lipids & lipid testing - the what, who, when, where, & why. Read it now!
Thanks @nationallipid! #LipidXcellence
Ann Liebeskind, MD retweeted
“One of my goals is of the issue of getting LDL cholesterol back as a quality metric. We’ve been working on this for the last several years, and I hope this is the year,” @CBallantyneMD @nationallipid #NLAsessions @EndocrineToday
Read more👇
healio.com/news/cardiology/2…
Ann Liebeskind, MD retweeted
Shoutout to the @nationallipid for the feature on Jeopardy last night!
What an incredible honor to be featured on Jeopardy last night!
@CBallantyneMD @dan_soffer @lipiddoc @Drlipid @DineshKalra
Ann Liebeskind, MD retweeted
📣 SAVE THE DATE: On Wed. 11/1 at 1PM ET, join a discussion of CVD's impact on minority communities and solutions to improve outcomes featuring @MHealthTeam, @kcferdmd, @DrRachelMBond, and @ijeomaheartdoc. RSVP here: bit.ly/40bO9m1.
Ann Liebeskind, MD retweeted
Check out "The Urgency to Treat Cardiovascular Disease in Women and Children" wonderful event Sept 27th ! @foundationofthenla @nationallipid @NationalMedAssn Featuring experts @MHealthTeam @DrMarthaGulati @FamilyHeartCMO
eventbrite.com/e/the-urgency… @Eventbrite
Ann Liebeskind, MD retweeted
Tomorrow our @FamilyHeartCMO will be joining @MHealthTeam from @foundationofnla and @DrMarthaGulati from the @ASPCardio for a @takehlth2heart webinar discussing CVD’s impact on women & children, & changes needed to improve outcomes. Register now! bit.ly/3Rm6aMg
Ann Liebeskind, MD retweeted
“To stop the rise in cardiovascular deaths, we must take action outside the clinic,” say @foundationofnla’s @MHealthTeam and @NationalMedAssn’s Dr. Millard Collins in new guest editorial. Read it in @nationallipid’s LipidSpin magazine here: bit.ly/46jSFl7.
Ann Liebeskind, MD retweeted
Time to change quality metrics and measure LDL-c #CMS #NCQA #HEDIS @nationallipid @ASPCardio @DrMarthaGulati @virani_md @VCUDPOSChair @dan_soffer @DrEugeneYang @vijay_nambi @MVarugheseMD @BCMHeart @BCM_CVRI @BCMDeptMedicine @Texas_Heart
#NLA2023 day 3 opens with Session IV, and a scientific statement update provided by @CBallantyneMD on the need for change in the #CMS quality metrics for #cholesterol @nationallipid #cardiotwitter
Ann Liebeskind, MD retweeted
Having way too much fun with fellow #LipidLovers at #NLASessions ! Looking forward to Day3!!
@EugeniaGianos @DrEugeneYang @lipiddoc @JSaseenPharmD @MHealthTeam @alanbrownmd @kcferdmd @aneeshathobani @shireen_khoury @CVOMed @AspryKarenMD @Dr_Zahid_Ahmad @ETSshow @dan_soffer
Ann Liebeskind, MD retweeted
📢You still have time to register for virtual live Foundations of Lipidology on Tues/Wed w/ @JSaseenPharmD @dan_soffer @carolkirkpat3 @MHealthTeam
FREE FOR TRAINEES! Learn more/register: lipid.org/foundations
Ann Liebeskind, MD retweeted
This is a course with knowledgeable and fantastic faculty- worth any clinicians investment to take best care of patients! Lipids are big piece of the ASCVD puzzle - checking, treating the right patients and monitoring are imperative and standard of care. Highly recommended course – at Texas, USA
NEXT WEEK our experts are live from their home office for 2 days lecturing on basic concepts & interactive learning scenarios providing knowledge & tools to work in a lipid practice.
If you are a trainee👉this Course is FREE
Learn more & register: lipid.org/foundations
Ann Liebeskind, MD retweeted
Thank you again to @MHealthTeam, @kcferdmd, and @naijaQRS for participating in our first expert-led webinar: A Policy Agenda to Stop the Rise in Cardiovascular Deaths!
To learn more about our initiative, visit takehealthtoheart.org.
LIVE: A Policy Agenda To Stop The Rise In Cardiovascular Deaths xitter.gq/i/broadcasts/1mnxeRYRR…
Ann Liebeskind, MD retweeted
It is estimated that 1 in 5 people have elevated Lp(a). Sadly most of them don't know they carry an excess of this most dangerous lipoprotein. We tell our patients #knowyournumbers. But this one is on us. Let's change the narrative.
#knowyourpatientsnumbers